6.4 Immunization Planning Across the Lifespan
Key Takeaways
- ACIP (CDC) is the FNP source of truth; schedules change, so know the age-band skeleton and live-vaccine cautions, then verify the current catch-up table and product job-aid.
- Pediatric backbone: birth HepB; infancy DTaP, IPV, Hib, PCV, rotavirus, and HepB; 12-month MMR, varicella, and HepA; 4–6-year boosters; 11–12-year Tdap, MenACWY, and HPV (HPV may start at 9).
- Influenza is planned for everyone 6 months and older; COVID follows the current seasonal ACIP note; RSV is planned in three conceptual lanes — pregnancy, infant antibody, and older-adult age/risk.
- Adult high-yield: RZV two-dose series at ≥50; universal HepB at 19–59; pneumococcal vaccine for all ≥65 and for 19–64 with risk, with product choice from the current ACIP figure; Td/Tdap every 10 years and Tdap with each pregnancy.
- Do not give live vaccines in pregnancy or severe immunocompromise. Vaccine hesitancy is a Planning problem: use motivational interviewing, do not invent a non-ACIP slow schedule.
Immunization sits on the Planning / Implementation seam. Domain III asks you to build the schedule. Domain IV asks you to give the dose, manage the reaction, and document lot number and VIS. This section is Planning: who needs what, which products are live, what cannot wait, and how you talk to a hesitant parent without inventing a catch-up table from memory.
ACIP is the FNP source of truth
In the United States the Advisory Committee on Immunization Practices (ACIP), adopted by CDC, is the schedule you plan from. Bright Futures tells you to immunize; ACIP tells you which antigen, how many doses, minimum intervals, and catch-up. Package inserts, school forms, and memory from NP school are not the authority when they disagree with the current catch-up table.
Schedules change. RSV products, COVID recommendations, pneumococcal conjugate names, and influenza composition have all moved in the mid-2020s. ANCC can fairly test principles and stable high-yield items. It cannot fairly require last Tuesday’s brand. Your exam behavior: know the age-band skeleton, know live-vaccine cautions, know pregnancy Tdap and influenza, and open the current ACIP child/adolescent or adult schedule (or the CDC job-aid) for catch-up and product choice. If you are unsure of a brand, write the indication group, not a guessed trade name.
Principles that do not go stale
- Simultaneous administration. Inactivated vaccines and most live vaccines can be given the same day at different sites. Two live injectable vaccines (MMR and varicella, for example) are given the same day or at least 4 weeks apart.
- Minimum intervals matter; extra time usually does not. A late series is continued, not restarted, for almost every routine childhood vaccine.
- Contraindication ≠ precaution ≠ myth. Anaphylaxis to a prior dose or a listed component is a contraindication. Moderate or severe acute illness is a reason to defer, not a lifetime ban. Mild URI and low-grade fever are not reasons to skip. Egg allergy is no longer a reason to withhold injectable influenza.
- Live vaccines (MMR, varicella, rotavirus, live-attenuated influenza, yellow fever, oral typhoid, and others on the current list) are not given in pregnancy and are generally avoided in severe immunocompromise (active chemotherapy, some biologics, high-dose steroids, untreated advanced HIV with very low CD4 — use the current ID/ACIP table). Household contacts may still receive MMR and varicella.
- DTaP versus Tdap. DTaP is the pediatric series for children younger than 7 years. From age 7 onward, catch-up and boosters use Tdap/Td. Do not give DTaP to an 11-year-old.
- Document VIS date, manufacturer, lot, site, and the name of the person giving the dose — Implementation, but you plan the workflow so it happens.
Pediatric high-yield skeleton (2025–2026)
Teach this backbone. Verify combination products and the exact PCV product on the current chart.
| Age band | Plan these antigens |
|---|---|
| Birth | HepB. If the birth dose was missed, start at the first visit. Infants of HBsAg-positive mothers also need HBIG and timely HepB — perinatal prevention, not a well-child luxury. |
| 2, 4, and 6 months (typical) | DTaP, IPV, Hib, PCV, rotavirus, and completing HepB. Rotavirus is oral and live. Do not start the series at or after 15 weeks 0 days; finish by 8 months 0 days. |
| 12–15 months | MMR, varicella, HepA (HepA is a 2-dose series; first dose 12–23 months), plus Hib and PCV boosters as indicated. |
| 4–6 years | Boosters: DTaP, IPV, MMR, varicella. |
| 11–12 years | Tdap, MenACWY, HPV. HPV routinely starts at 11–12 and may start at 9. Two-dose HPV if the series begins before the 15th birthday; three doses if started at 15 or later, or if the patient is immunocompromised. MenACWY booster at 16. |
| Every influenza season | All persons ≥6 months who have no contraindication. Age and prior-dose history decide whether a child needs 1 or 2 doses that season — use the current influenza note, do not guess. |
| COVID-19 | Follow current seasonal ACIP for product, dose count, and pregnancy or immunocompromise notes. Do not memorize a retired brand schedule. |
MenB is not in the 11–12 automatic trio. It is a shared clinical decision at 16–23 years (preferred 16–18) and is indicated for certain risk groups (asplenia, complement deficiency, outbreak). Do not fail an item by stuffing MenB into every 11-year-old.
Hib is generally not started after the fifth birthday except in special conditions (asplenia, HIV, and others on the current table). Rotavirus is not a toddler catch-up antigen once the age windows have closed.
Live-virus timing with blood products and tuberculin skin testing is a catch-up detail. If the stem gives recent immune globulin or a planned TST, separate them per the current table rather than inventing days.
Adult high-yield skeleton
| Indication group | Plan |
|---|---|
| Influenza | Every season, all adults. |
| COVID-19 | Current ACIP seasonal recommendation. |
| Td or Tdap | Booster every 10 years. Give Tdap once if the adult never had it, then Td or Tdap. Every pregnancy: Tdap at 27–36 weeks (or as soon as possible if that window is missed) — each pregnancy, not once in a lifetime. |
| HPV | Catch-up through age 26 if not completed. Ages 27–45: shared decision. |
| HepB | Universal for adults 19–59. Age 60 and older: vaccinate if risk is present or if the patient wants protection. Do not leave a 45-year-old unvaccinated because “HepB is for kids and healthcare workers.” |
| HepA | Risk-based (travel, liver disease, MSM, houselessness, selected occupational and outbreak settings) plus catch-up if indicated. |
| MMR / varicella | Adults without immunity: vaccinate unless pregnant or severely immunocompromised. Rubella immunity matters before pregnancy; do not give MMR in pregnancy. |
| RZV (recombinant zoster) | 2-dose series at age ≥50, regardless of prior chickenpox or prior live zoster vaccine. Also indicated in many immunocompromised adults ≥19 — check the current immunocompromised schedule. This is not the retired live zoster vaccine. |
| Pneumococcal | Two indication groups, not a brand you invent: (1) all adults ≥65; (2) adults 19–64 with risk (immunocompromise, cochlear implant, CSF leak, chronic heart/lung/liver disease, diabetes, cigarette smoking, alcoholism, and others on the current list). Product choice — PCV15 followed by PPSV23, or a single PCV20 or PCV21, or whatever ACIP currently lists — follows the job-aid in force the day you order. If names are in flux on exam day, pick the group and say you will use the current adult pneumococcal figure. |
| RSV | Three conceptual lanes: maternal vaccination during the current ACIP gestational window in RSV season; infant monoclonal antibody when the infant is not protected by a timely maternal dose (or as otherwise indicated); and older-adult vaccination by age and risk (recent seasons have used an age cutoff plus a risk-based band — verify the current age/risk table; do not lock a single brand). |
| Travel, mpox, rabies, typhoid | Indication- and exposure-driven. Do not put them on a default 30-year-old wellness plan. |
Pregnancy and immunocompromise
In pregnancy, plan inactivated influenza (any trimester), Tdap each pregnancy, COVID per current ACIP, and RSV vaccine if the person is in the seasonal gestational window ACIP currently names. Give HepB if the person is not immune. Do not give MMR, varicella, live-attenuated influenza, or other live vaccines. If a live vaccine is given inadvertently, that is a counseling and reporting event — it is not an automatic recommendation for termination, and you should not invent a percentage risk on the exam.
Severe immunocompromise: avoid live vaccines; inactivated vaccines are often indicated more strongly (influenza, COVID, pneumococcal, HepB, RZV) but may be less immunogenic. Time doses around rituximab or chemotherapy using specialty guidance. Asplenia adds meningococcal (ACWY and B) and pneumococcal urgency.
Hesitancy is a planning problem
A refused dose is a plan that did not survive the conversation. Use motivational interviewing (open questions, affirmations, reflections, summaries — details in the later communication chapter): ask what the parent has heard, affirm the desire to protect the child, reflect the specific fear (autism, “too many, too soon,” fertility, myocarditis), and share the one fact that addresses that fear. Do not stack twelve antigens of lecture. Do not dismiss. Do not bargain by inventing a non-ACIP “slow schedule” as if it were evidence-based. You may space visits for rapport, but you do not create a new scientific schedule. Document informed refusal and leave the door open. School-exclusion rules are public-health Implementation, not a punishment you improvise.
Vignette 1. An 11-year-old is due for well care. She had childhood DTaP/IPV/MMR/varicella/HepA/HepB on time and has never had Tdap, MenACWY, or HPV. Influenza season is open. The plan is Tdap + MenACWY + HPV dose 1 today, seasonal influenza, COVID if due per current ACIP, and a reminder that HPV dose 2 is due in 6–12 months because she is starting before age 15. MenB is a discussion for later adolescence unless a risk factor is present.
Vignette 2. A 67-year-old man has never received pneumococcal or HepB vaccine, had shingles at 61, and his last tetanus shot was “in the Army.” The plan is the RZV two-dose series (prior zoster does not exempt him), the HepB universal adult series, pneumococcal immunization for the ≥65 group using the current ACIP product figure, Tdap if he never had it as an adult (then 10-year boosters), plus influenza and COVID per season. You do not write “PPSV23 only, live zoster, skip HepB.”
If a stem hands you an incomplete record, rebuild from documented doses and minimum intervals. Do not restart DTaP because the parent lost the card — obtain the immunization information system (state registry) first. The catch-up table is the tool; your memory is not a substitute for it.
An 11-year-old has completed the routine childhood series through age 6. Which immunization plan is appropriate today?
A 29-year-old is at 30 weeks of pregnancy during influenza season. Which immunization plan is correct?
A 52-year-old immunocompetent adult has never had zoster vaccine, does not know hepatitis B status, and last received tetanus immunization 12 years ago. Using current ACIP principles, what should the FNP plan?
A healthy 2-month-old is due for well care. Birth hepatitis B was given in the nursery. Which plan matches the infant immunization skeleton?